Skip to main content

Without a test, medicine is blind, and lives are put at risk. Diagnostics are the first step of care and the backbone of a resilient, better prepared health system. Yet, for nearly half of the world’s population they out of reach1—leaving millions at risk of the devastating consequences of preventable deaths.

As global health is changing, advancing it has become increasingly complex. With limited resources and competing priorities, countries need to ensure investments can yield the greatest impact—on people, on communities, on economies, and on national security. 

When countries invest in integrated laboratory networks, resources go further, local expertise grows, and health systems become stronger. The impact reaches far beyond clinical settings—improving health outcomes creates skilled jobs, empowers populations, and helps local economies thrive.

A scientist in a lab coat and gloves operates lab equipment, handling a rack of test tubes. The lab setting is organized and focused.

When countries invest in robust, integrated laboratory networks, access to diagnostics can spread so that preventable diseases and global health threats cannot.

Since 2020, Roche and (RED) have partnered to increase awareness about diagnostics and advocate for country-led initiatives that help strengthen diagnostics capacity and expand access to reliable testing in low- and middle-income countries. Together, we harnessed creative collaboration and (RED)’s powerful global voice to spotlight a vital truth: laboratory network readiness is the foundation of resilient health systems.

Through our joint efforts, we highlighted how a skilled workforce, reliable supply chains, and AI-enabled laboratory innovations come together to prevent disease, detect conditions earlier, and stop local outbreaks before they spread.

Over the course of our work together, we helped amplify (RED)’s mission, which has generated more than $800 million for the Global Fund, positively impacting over 350 million lives and building a foundation for an HIV-free generation.

(RED) X Roche

Together, we remain united in our commitment to making preventable and treatable diseases preventable and treatable for everyone, everywhere—helping countries to be better prepared to address public health needs today and become more resilient for the future.

About (RED)®: 20 years of impact

Founded by Bono & Bobby Shriver in 2006 to fight AIDS, (RED) partners with the world’s most iconic brands and people to create products and experiences that raise money, heat and urgency for global health crises. 

Every action you take with (RED) saves lives. 

To date, (RED) has generated over $800 million for the Global Fund, helping more than 350 million people. (RED) funding supports life-saving programs that empower health workers and provide testing, treatment and care in places where injustice has enabled pandemics to thrive.

References

  1. The Lancet Commission on diagnostics: transforming access to diagnostics. 2021. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00467-8/fulltext Last accessed on August 2024

  2. UNAIDS. 2025. Global HIV statistics. Available on https://www.unaids.org/en/resources/fact-sheet Last accessed on June 2026

Discover more

Global Access Program

About Roche

Since 2014, our Roche Global Access Program has provided a mechanism to combine our innovation and expertise to establish diagnostics as a backbone for more resilient health systems.

More stories of

See all stories